Dermata Therapeutics Stock Market Value
| DRMA Stock | USD 1.14 0.01 0.87% |
| Symbol | Dermata |
Dermata Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.36) | Return On Assets (0.91) | Return On Equity (1.73) |
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dermata Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dermata Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dermata Therapeutics.
| 10/25/2024 |
| 11/24/2024 |
If you would invest 0.00 in Dermata Therapeutics on October 25, 2024 and sell it all today you would earn a total of 0.00 from holding Dermata Therapeutics or generate 0.0% return on investment in Dermata Therapeutics over 30 days. Dermata Therapeutics is related to or competes with Zura Bio, Phio Pharmaceuticals, Sonnet Biotherapeutics, 180 Life, Cardio Diagnostics, Windtree Therapeutics, and Ensysce Biosciences. Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializ... More
Dermata Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dermata Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dermata Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 69.06 | |||
| Value At Risk | (8.05) | |||
| Potential Upside | 9.22 |
Dermata Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dermata Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dermata Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dermata Therapeutics historical prices to predict the future Dermata Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.74) | |||
| Treynor Ratio | (0.27) |
Dermata Therapeutics Backtested Returns
Dermata Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0355, which denotes the company had a -0.0355% return per unit of risk over the last 3 months. Dermata Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dermata Therapeutics' Standard Deviation of 8.31, variance of 69.11, and Mean Deviation of 4.98 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.6, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dermata Therapeutics will likely underperform. At this point, Dermata Therapeutics has a negative expected return of -0.3%. Please make sure to confirm Dermata Therapeutics' value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Dermata Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.92 |
Excellent predictability
Dermata Therapeutics has excellent predictability. Overlapping area represents the amount of predictability between Dermata Therapeutics time series from 25th of October 2024 to 9th of November 2024 and 9th of November 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dermata Therapeutics price movement. The serial correlation of 0.92 indicates that approximately 92.0% of current Dermata Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.92 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Dermata Therapeutics lagged returns against current returns
Autocorrelation, which is Dermata Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dermata Therapeutics' stock expected returns. We can calculate the autocorrelation of Dermata Therapeutics returns to help us make a trade decision. For example, suppose you find that Dermata Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dermata Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dermata Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dermata Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dermata Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Dermata Therapeutics Lagged Returns
When evaluating Dermata Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dermata Therapeutics stock have on its future price. Dermata Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dermata Therapeutics autocorrelation shows the relationship between Dermata Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Dermata Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dermata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermata Therapeutics Stock:Check out Dermata Therapeutics Correlation, Dermata Therapeutics Volatility and Dermata Therapeutics Alpha and Beta module to complement your research on Dermata Therapeutics. For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Dermata Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.